Observational study assessing adverse reactions of Pfizer-BioNTech COVID-19 mRNA vaccine with in children aged 5-11 years across Kaiser Permanente Southern California
Latest Information Update: 14 Nov 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 14 Nov 2022 New trial record
- 03 Nov 2022 Results published in the Vaccine